In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
about
Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future TherapiesDendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft SurvivalVirological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapyThe attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cellsAntigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regressionCovalent decoration of adenovirus vector capsids with the carbohydrate epitope αGal does not improve vector immunogenicity, but allows to study the in vivo fate of adenovirus immunocomplexesImmunity, immunopathology, and human vaccine development against sexually transmitted Chlamydia trachomatisTargeting human dendritic cells in situ to improve vaccines.Targeting the C-type lectins-mediated host-pathogen interactions with dextranTargeting C-type lectin receptors: a high-carbohydrate diet for dendritic cells to improve cancer vaccinesIn vivo targeting of protein antigens to dendritic cells using anti-DEC-205 single chain antibody improves HIV Gag specific CD4(+) T cell responses protecting from airway challenge with recombinant vaccinia-gag virus.Targeting Mycobacterium tuberculosis Antigens to Dendritic Cells via the DC-Specific-ICAM3-Grabbing-Nonintegrin Receptor Induces Strong T-Helper 1 Immune Responses.Mouse DC-SIGN/CD209a as Target for Antigen Delivery and Adaptive Immunity.The Long Noncoding RNA MALAT1 Induces Tolerogenic Dendritic Cells and Regulatory T Cells miR155/Dendritic Cell-Specific Intercellular Adhesion Molecule-3 Grabbing Nonintegrin/IL10 Axis
P2860
Q26752558-7CCE8A26-8127-4E70-9871-5EC8F47F6DCAQ30681903-391352F8-2248-4FFA-9C3A-C1418D175E2BQ35069876-13BDB55D-0323-473E-BE73-1B7702F1E366Q35832233-2351359F-E268-45A1-96B7-22FA2F73DEC2Q36060263-5C2AD4FC-F5A8-45C4-BA95-55B4344FA28DQ36363270-1F3C63C4-C579-4347-B186-B706B763B3C2Q37159712-4F86C4E8-C0F2-4784-A098-FF4EEA2BB66DQ38235001-260AF98C-47AB-4D97-B033-0C592621E355Q38249917-4ACFE587-2A05-4870-9977-A472995B79DAQ39448911-FC65E581-9936-4E9A-B415-BE33B580192DQ40214060-B5C1CC84-B445-4115-B8FB-AEBCC508C069Q52584422-048D7455-0E58-43CD-B0B6-CBCAC64663CEQ55005132-9C44DD7B-B549-4AA2-B199-02DD2B65A314Q58785770-9C93A6B1-7DEE-49E1-BA5B-092323B0E205
P2860
In vivo targeting of human DC-SIGN drastically enhances CD8⁺ T-cell-mediated protective immunity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
In vivo targeting of human DC- ...... -mediated protective immunity.
@en
In vivo targeting of human DC- ...... -mediated protective immunity.
@nl
type
label
In vivo targeting of human DC- ...... -mediated protective immunity.
@en
In vivo targeting of human DC- ...... -mediated protective immunity.
@nl
prefLabel
In vivo targeting of human DC- ...... -mediated protective immunity.
@en
In vivo targeting of human DC- ...... -mediated protective immunity.
@nl
P2093
P2860
P356
P1476
In vivo targeting of human DC- ...... -mediated protective immunity.
@en
P2093
Abdul Mannan Baru
Catharina Arnold-Schrauf
Christian T Mayer
Christina Hesse
Hakan Kalay
Luciana Berod
Theresa Förg
Tim Sparwasser
Wendy W J Unger
Wiebke Ginter
P2860
P304
P356
10.1002/EJI.201343429
P407
P577
2013-07-22T00:00:00Z